Skip to main content

Neal Fowler's new Triangle pharma raises $150M despite tough funding environment

The former Liquidia CEO's new pharmaceutical venture plans to launch phase 3 studies this year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.